IP Library Granted Patent US 11,957,459
Granted Patent B2
US 11,957,459 · App. 17/552,264 · Granted Apr 16, 2024

Method and/or system for determining blood glucose reference sample times

Inventors: Rebecca K. Gottlieb (Culver City, CA); Meena Ramachandran (San Francisco, CA)
Assignee: Medtronic MiniMed, Inc.
A61B5/14532A61B5/14503A61B5/4839A61B5/6849A61B5/7221A61B5/742A61M5/14244A61M5/1723A61M2005/14208A61M2205/18A61M2205/50A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,957,459
App. No.
17/552,264
Granted
Apr 16, 2024
Kind
B2
Abstract

Subject matter disclosed herein relates to monitoring and/or controlling blood glucose levels in patients. In particular, times for obtaining metered blood glucose samples of a patient may be altered based, at least in part, on a blood glucose level of said patient observed from a blood glucose sensor.

Claims (29)

1. A method comprising:

determining a first glucose level reference sample measurement for a patient based on signals from a continuous glucose sensor;

determining to extend a scheduled time for determining a second glucose level reference sample measurement based on a reliability indicator (RI) indicating a reliability of the continuous glucose sensor satisfying a threshold; and

in response to determining to extend the scheduled time, generating signals to provide a message indicating an option to extend the scheduled time for determining the second glucose level reference sample measurement.

2. The method of claim 1 , wherein the RI is based on one or more trends in the signals from the continuous glucose sensor.

3. The method of claim 2 , wherein the one or more trends comprise a reduced sensitivity of the continuous glucose sensor.

4. The method of claim 2 , wherein the one or more trends comprise one or more of non-physiological anomalies or sensor drift.

5. The method of claim 1 , wherein determining to extend the scheduled time is further based on an observed glucose level being within a target range and wherein the observed glucose level is based on the signals from the continuous glucose sensor.

6. The method of claim 1 , wherein determining to extend the scheduled time is further based on an observed glucose level being in a target range for more than a threshold duration and wherein the observed glucose level is based on the signals from the continuous glucose sensor.

7. The method of claim 6 , wherein the RI is based on one or more trends in the signals from the continuous glucose sensor.

8. The method of claim 7 , wherein the one or more trends comprise a reduced sensitivity of the continuous glucose sensor.

9. The method of claim 8 , wherein the one or more trends comprise one or more of non-physiological anomalies or sensor drift.

10. The method of claim 1 , wherein the generating of the signals to provide the message comprises causing a display of the message indicating the option to extend the scheduled time for determining the second glucose level reference sample measurement.

11. An apparatus comprising one or more processors configured to:

determine a first glucose level reference sample measurement for a patient based on signals from a continuous glucose sensor;

determine to extend a scheduled time for determining a second glucose level reference sample measurement based on a reliability indicator (RI) indicating a reliability of the continuous glucose sensor satisfying a threshold; and

in response to the determination to extend the scheduled time, generate signals to provide a message indicating an option to extend the scheduled time for determining the second glucose level reference sample measurement.

12. The apparatus of claim 11 , wherein the RI is based on one or more trends in the signals from the continuous glucose sensor.

13. The apparatus of claim 12 , wherein the one or more trends comprise a reduced sensitivity of the continuous glucose sensor.

14. The apparatus of claim 12 , wherein the one or more trends comprise one or more of non-physiological anomalies or sensor drift.

15. The apparatus of claim 11 , wherein, to determine to extend the scheduled time, the one or more processors are configured to determine to extend the scheduled time based further on an observed glucose level being within a target range and wherein the observed glucose level is based on the signals from the continuous glucose sensor.

16. The apparatus of claim 11 , wherein, to determine to extend the scheduled time, the one or more processors are configured to determine to extend the scheduled time based further on an observed glucose level being within a target range for more than a threshold duration and wherein the observed glucose level is based on the signals from the continuous glucose sensor.

17. The apparatus of claim 16 , wherein the RI is based on one or more trends in the signals from the continuous glucose sensor.

18. The apparatus of claim 17 , wherein the one or more trends comprise a reduced sensitivity of the continuous glucose sensor.

19. The apparatus of claim 17 , wherein the one or more trends comprise one or more of non-physiological anomalies or sensor drift.

20. A non-transitory computer readable storage medium storing instructions that, when executed, cause one or more processors to:

determine a first glucose level reference sample measurement for a patient based on signals from a continuous glucose sensor;

determine to extend a scheduled time for determining a second glucose level reference sample measurement based on a reliability indicator (RI) indicating a reliability of the continuous glucose sensor satisfying a threshold; and

in response to the determination to extend the scheduled time, generate signals to provide a message indicating an option to extend the scheduled time for determining the second glucose level reference sample measurement.

Assignments (2)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2022
From: GOTTLIEB, REBECCA K.; RAMACHANDRAN, MEENA
To: MEDTRONIC MINIMED, INC.
Reel/Frame 059667/0796 →
Continuity (6)
Continuation 16559416 · Sep 3, 2019
Continuation 15268063 · Sep 16, 2016
Continuation 13171244 · Jun 28, 2011
Provisional Application 61407888 · Oct 28, 2010
Provisional Application 61361876 · Jul 6, 2010
Related Publication 20220104734A1 · Apr 7, 2022
Cited By (1)
US 12,635,916